Murine polyomarivus-VP1 virus-like particles immunize against some polyomavirus-induced tumours

In Vivo

Volumn 19, Issue 2, 2005, Pages 323-326

  Franzén, Andrea Vlastos ^a   Tegerstedt, Karin ^a   Holländerová, Dana ^b   Forstová, Jitka ^b   Ramqvist, Torbjörn ^a   Dalianis, Tina ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Immunization; Polyomarivus; TSTA; VLP

Indexed keywords

CANCER VACCINE; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; PROTEIN VP1; VIRUS ANTIGEN; VIRUS VACCINE; CAPSID PROTEIN; TUMOR ANTIGEN; VP1 PROTEIN, POLYOMAVIRUS;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CONTROLLED STUDY; FIBROSARCOMA; MOUSE; NONHUMAN; POLYOMA VIRUS; SARCOMA; SKIN TUMOR; TUMOR GROWTH; VIRUS CARCINOGENESIS; VIRUS INFECTION; VIRUS LOAD; VIRUS PARTICLE; ANIMAL; CANCER TRANSPLANTATION; CBA MOUSE; EXPERIMENTAL NEOPLASM; GENETICS; IMMUNIZATION; IMMUNOLOGY; PATHOLOGY; TUMOR CELL LINE; VIRUS REPLICATION;

ANIMALS; ANTIGENS, NEOPLASM; CAPSID PROTEINS; CELL LINE, TUMOR; GLUTATHIONE TRANSFERASE; IMMUNIZATION; MICE; MICE, INBRED CBA; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; RECOMBINANT FUSION PROTEINS; TUMOR VIRUS INFECTIONS; VIRUS REPLICATION;

EID: 16344385992     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Cole N: Polyomavirinae: the viruses and their replication. In: Fields BN et al., editors. Virology, 3rd ed. Philadelphia PA: Lippincott-Raven, Philadelphia, pp 1997-2025, 1996.
2. Allison AC: Immune responses to polyoma virus and polyoma virus induced tumors, In: Klein G, editor. Viral Oncology. New York:Raven Press, pp 481-7, 1980.
3. Berke Z and Dalianis T: Studies on polyomavirus persistence and polyomavirus induced tumor development in relation to the immune system. Adv Cancer Res 79: 249-279, 2000.
4. Vlastos A, Andreasson K, Tegerstedt K, Hollanderova D, Heidari S, Forstova J et al: VP1 pseudocapsids, but not a glutathione-S-transferase VP1 fusion protein prevent polyomavirus infection in a T-cell immune deficient experimental mouse model. J Med Virol 70: 293-300, 2003.
5. Dalianis T: Studies on the polyoma virus tumor-specific transplantation antigen (TSTA). Adv Cancer Res 55: 57-85, 1980.
6. Ramqvist T, Reinholdsson G, Szigeti R, Klein G and Dalianis T: Studies on the polyoma tumor-specific transplantation antigen (TSTA): selection and characterization of TSTA-negative segregants from somatic hybrids. Int J Cancer 40: 74-80, 1987.
7. Berke Z, Palmer S, Bergman T, Wester D, Svedmyr J, Linder S et al: A short peptide eluted from the H-2Kb molecule of a polyomavirus-positive tumor corresponds to polyomavirus large T antigen peptide at amino acids 578 to 585 and induces polyomavirus-specific immunity. J Virol 70: 3093-7, 1996.
8. Chen L and Fluck MM: Role of middle T-small T in the lytic cycle of polyomavirus: control of the early-to-late transcriptional switch and viral DNA replication. J Virol 75: 8380-9, 2001.
9. Mayer M and Dörries K: Nucleotide sequence and genome organization of the murine polyomavirus, Kilham strain. Virology 181 469-480, 1991.
10. Tegerstedt K, Andreasson K, Vlastos A, Hedlund KO, Dalianis T and Ramqvist T: Murine pneumotropic virus VP1 virus-like particles (VLPs) bind to several cell types independent of sialic acid residues and do not serologically cross react with murine polyomavirus VP1 VLPs. J Gen Virol 84: 3443-3452, 2003.
11. Dalianis T, Magnusson G, Ito Y and Klein G: Immunization against the polyoma virus-induced tumor-specific transplantation antigen by early region mutants of the virus. J Virol 43: 772-7, 1982.
12. Trivedi P, Masucci MG, Winberg G and Klein G: The Epstein-Barr-virus-encoded membrane protein LMP but not the nuclear antigen EBNA-1 induces rejection of transfected murine mammary carcinoma cells. Int J Cancer 48: 794-800, 1991.
13. Heidari S, Krauzewicz N, Kalantari M, Vlastos A, Griffin BE and Dalianis T: Persistence and tissue distribution of DNA in normal and immunodeficient mice inoculated with polyomavirus VP1 pseudocapsid complexes or polyomavirus. J Virol 74: 11963-5, 2000.
14. De Bruijn M L, Greenstone HL, Vermeulen H, Melief CJ, Lowy DR, Schiller JT et al: L1-specific protection from tumor challenge elicited by HPV16 virus-like particles. Virology 250: 371-6, 1998.